Background Atrial fibrillation and heart failure often coexist, causing substantial cardiovascular
morbidity and mortality. β blockers are indicated in patients with symptomatic heart failure …

Aims Recent guidelines recommend that patients with heart failure and left ventricular ejection
fraction (LVEF) 40–49% should be managed similar to LVEF ≥ 50%. We investigated the …

Aims To evaluate whether the addition of hydrochlorothiazide (HCTZ) to intravenous
furosemide is a safe and effective strategy for improving diuretic response in acute heart failure (…

Background : The relationship between mortality and heart rate remains unclear for patients
with heart failure with reduced ejection fraction in either sinus rhythm or atrial fibrillation (AF)…

Aims Heart failure (HF) in the elderly carries a poor prognosis. We used the SENIORS dataset
of elderly HF patients aged ≥70 years in order to develop a risk model for this population. …

Objectives To determine the efficacy and tolerability of β blockers in a broad age range of
women and men with heart failure with reduced ejection fraction (HFrEF) by pooling individual …

Background Whether immunosuppressed (IS) patients have a worse prognosis of COVID-19
compared to non-IS patients is not known. The aim of this study was to evaluate the clinical …

Introduction and objectives Although heart failure negatively affects the health-related quality
of life of Spanish patients there is little information on the clinical factors associated with …

Background: Despite being associated with worse prognosis in patients with COVID-19,
systematic determination of myocardial injury is not recommended. The aim of the study was to …

Despite the increasing evidence of the benefit of corticosteroids for the treatment of
moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available about the …